C. Garbe, S. Abusaif, T. K. Eigentler: Vemurafenib. In: Recent results in cancer research. Fortschritte der Krebsforschung. Progre?s dans les recherches sur le cancer. Band 201, 2014, S. 215–225. doi:10.1007/978-3-642-54490-3_13. PMID 24756795 (Review).
D. Capper, A. S. Berghoff, M. Magerle, A. Ilhan, A. Wöhrer, M. Hackl, J. Pichler, S. Pusch, J. Meyer, A. Habel, P. Petzelbauer, P. Birner, A. von Deimling, M. Preusser: Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases. In: Acta Neuropathol. 123(2), Feb 2012, S. 223–233. doi:10.1007/s00401-011-0887-y.
D. Capper, M. Preusser, A. Habel, F. Sahm, U. Ackermann, G. Schindler, S. Pusch, G. Mechtersheimer, H. Zentgraf, A. von Deimling: Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. In: Acta Neuropathol. 122(1), Jul 2011, S. 11–19. doi:10.1007/s00401-011-0841-z.
R. Dummer, K. T. Flaherty: Resistance patterns with tyrosine kinase inhibitors in melanoma: new insights. In: Current Opinion in Oncology. Band 24, Nummer 2, März 2012. PMID 22316627. (Review).
J. Avruch, A. Khokhlatchev, J. M. Kyriakis, Z. Luo, G. Tzivion, D. Vavvas, X. F. Zhang: Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. In: Recent Prog Horm Res. 56, 2001, S. 127–155. PMID 11237210
G. Pearson, F. Robinson, T. Beers Gibson, B. E. Xu, M. Karandikar, K. Berman, M. H. Cobb: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. In: Endocrine Reviews. 22(2), Apr 2001, S. 153–183. PMID 11294822
C. Garbe, S. Abusaif, T. K. Eigentler: Vemurafenib. In: Recent results in cancer research. Fortschritte der Krebsforschung. Progre?s dans les recherches sur le cancer. Band 201, 2014, S. 215–225. doi:10.1007/978-3-642-54490-3_13. PMID 24756795 (Review).
